Intas Pharmaceuticals

Rediff.com » News » Intas Pharmaceuticals

News for Intas Pharmaceuticals

Business

Why Zydus is likely to continue with its outperformance

Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past......

Indian pharma firms working on new repurposed drug for Covid-19

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations. Domestic drug firms are working on re-purposed drugs that......

PE/VC investments in pharma cos cross $1 bn mark

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma......

Birlas to pick up 49% in Intas Bio

The Aditya Birla group is likely to pick up 49 per cent stake in the biotechnology business of the Ahmedabad-based Intas Pharmaceuticals. The promoters are planning to divest a substantial stake in......

Brick-and-mortar billionaires back on Forbes rich list

Top 100 billionaires see their wealth rise 10%; top 20 account for half of total wealth of top 100. The top 20 billionaires in the Forbes India rich list have seen their wealth as a percentage of......

Rediff News

Intas Pharmaceuticals

News for Intas Pharmaceuticals

Why Zydus is likely to continue with its outperformance

Indian pharma firms working on new repurposed drug for Covid-19

PE/VC investments in pharma cos cross $1 bn mark

Birlas to pick up 49% in Intas Bio

Brick-and-mortar billionaires back on Forbes rich list

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS